These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 16606758

  • 1. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A.
    Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
    [Abstract] [Full Text] [Related]

  • 2. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.
    JAMA; 2005 May 25; 293(20):2496-500. PubMed ID: 15914750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P.
    Mult Scler; 2013 Oct 25; 19(12):1587-91. PubMed ID: 23549431
    [Abstract] [Full Text] [Related]

  • 5. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
    Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A.
    Mult Scler; 2011 Oct 25; 17(10):1185-93. PubMed ID: 21685232
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus and multiple sclerosis.
    Pohl D.
    J Neurol Sci; 2009 Nov 15; 286(1-2):62-4. PubMed ID: 19361810
    [Abstract] [Full Text] [Related]

  • 8. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.
    Kroc Found Ser; 1985 Nov 15; 19():287-300. PubMed ID: 2999343
    [Abstract] [Full Text] [Related]

  • 9. Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis.
    Massa J, Munger KL, O'Reilly EJ, Falk KI, Ascherio A.
    Neuroepidemiology; 2007 Nov 15; 28(4):214-5. PubMed ID: 17851260
    [Abstract] [Full Text] [Related]

  • 10. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M, Leng Y, Bjornevik K, Mitchell M, Healy BC, Mina MJ, Mancuso JD, Niebuhr DW, Munger KL, Elledge SJ, Ascherio A.
    JAMA Neurol; 2024 May 01; 81(5):515-524. PubMed ID: 38497939
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus and multiple sclerosis.
    Lovett-Racke AE, Racke MK.
    Arch Neurol; 2006 Jun 01; 63(6):810-1. PubMed ID: 16769860
    [No Abstract] [Full Text] [Related]

  • 12. Multiple sclerosis and Epstein-Barr virus.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.
    JAMA; 2003 Mar 26; 289(12):1533-6. PubMed ID: 12672770
    [Abstract] [Full Text] [Related]

  • 13. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N.
    Srp Arh Celok Lek; 1998 Mar 26; 126(3-4):97-100. PubMed ID: 9863363
    [Abstract] [Full Text] [Related]

  • 14. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ, Munger KL, Ascherio A.
    Eur J Neurol; 2004 Dec 26; 11(12):833-4. PubMed ID: 15667414
    [Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C.
    J Neuroimmunol; 2014 Jul 15; 272(1-2):56-61. PubMed ID: 24798244
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.
    Neurology; 2009 Jul 07; 73(1):32-8. PubMed ID: 19458321
    [Abstract] [Full Text] [Related]

  • 18. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D.
    Mult Scler; 2014 Mar 07; 20(3):286-94. PubMed ID: 23886832
    [Abstract] [Full Text] [Related]

  • 19. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May 07; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 20. Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals.
    Nielsen TR, Pedersen M, Rostgaard K, Frisch M, Hjalgrim H.
    Mult Scler; 2007 Apr 07; 13(3):420-3. PubMed ID: 17439912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.